Pinned Tweet
We are hiring #drugdiscovery and #AI talents! It's an exciting time at Pangea Botanica and Kanna Health, one of our operating companies. We have a number of open roles and also welcome proactive applications. For more info, please check out the link below
linkedin.com/posts/thomas-pf…
Thomas Pfeiffer retweeted
It was great fun to work on this preprint with @robmlees @ibianco3 @raacampbell @natorlova Darcy Peterka @labrigger @YatsenkoDimitri Che-Hang Yu & @paqio.
Hope this helps many people to characterise their 2p microscopes biorxiv.org/content/10.1101/…
Thomas Pfeiffer retweeted
Interested in prodrugs? This review in the June issue analyses approved prodrugs and discusses trends in their development, design rationales, indications, mechanisms of API release, chemistry of promoieties and market impact bit.ly/43I3X1U rdcu.be/dIGPU
Thomas Pfeiffer retweeted
The state of the art in secondary pharmacology and its impact on the safety of new medicines bit.ly/3WRAWiW
This new article discusses best practices in secondary pharmacology screening, including safety-associated targets not covered by most current screening panels
Thomas Pfeiffer retweeted
Hundreds of thousands of potential psychedelics discovered by docking against predicted and real structures of 5-HT2A
#psychedelics
"AlphaFold2 structures guide prospective ligand discovery"
science.org/doi/10.1126/scie…
Thomas Pfeiffer retweeted
Parvalbumin interneuron activity in autism underlies susceptibility to PTSD-like memory formation: iScience cell.com/iscience/fulltext/S…
Thomas Pfeiffer retweeted
It's #FluorescentFriday!
What happens in the brain during normal aging?
While most neurons will not shrink, they will lose synapses, the connections between different neurons, which can affect learning and memory.
But how do we take these images from primates? (1/5)
Thomas Pfeiffer retweeted
🧠 Curious about how neurons are wired in the human cortex?
Our @ScienceMagazine study tested over 7,000 connections and revealed key differences from rodents:
"Directed and acyclic synaptic connectivity in the human layer 2-3 cortical microcircuit". 🧵👇science.org/doi/10.1126/scie…
Thomas Pfeiffer retweeted
There's never been a disease-modifying drug for Parkinson's disease to slow its progression. Now there may be two emerging.
—GLP-1
nejm.org/doi/abs/10.1056/NEJ… @NEJM
—anti-synuclein antibody nature.com/articles/s41591-0…
@NatureMed
Thomas Pfeiffer retweeted
Researchers at AD/PD 2024 discussed progress in developing disease-modifying therapies for synucleinopathies. #parkinsonsdisease @adpdnet ow.ly/sPMC50RcMUi
Thomas Pfeiffer retweeted
Delighted to announce Prof David Attwell (@ucl) as Centre Director of our groundbreaking new Centre for Vascular Dementia Research, a partnership with @TheBHF!🎉👏
Prof Attwell's extensive experience brings a wealth of leadership & vision to the role👉buff.ly/3PQbDJL
Thomas Pfeiffer retweeted
We have open positions for a postdoc and a research assistant in the beautiful city of Edinburgh at the @UKDRI! Reach out if you want to know more about either of the positions!
Postdoctoral Research Fellow in the Hasel Lab @HaselPhilip at @UKDRI - University of Edinburgh to explore how astrocytes at the borders of the brain contribute to brain function and dysfunction in disease. Closing date: 26th April.
dementiaresearcher.nihr.ac.u…
Thomas Pfeiffer retweeted
The landscape of small-molecule prodrugs bit.ly/43I3X1U
This new review analyses approved prodrugs to reveal trends in their development, highlighting design rationales, indications, mechanisms of API release, chemistry of promoieties and the market impact of prodrugs
Thomas Pfeiffer retweeted
My brand-new lab website is now LIVE!
misa-arizono.com
Thank you, merci, arigato to everyone who helped me get to this point.
Thomas Pfeiffer retweeted
Check out these exciting startups and the promising work they are doing to promote brain health.
📢 Today we announce the 2024 cohort of the #OneMindAccelerator program!
By supporting these 10 startups, One Mind seeks to advance precision psychiatry and make quality mental healthcare accessible, affordable & equitable.
Learn more: businesswire.com/news/home/2…
Day 1 for Pangea Bio at #ADPD2024 in Lisbon! I can't wait to discuss our lead compound OT-003's potential for treating PD and other neurodegenerative diseases. Get in touch if you wish to meet and visit us at our poster # 0530 on Friday & Saturday (lnkd.in/e3Dsqx-U).
Thomas Pfeiffer retweeted
Active neurons can stimulate the clearance of their own metabolic waste by driving changes to ion gradients in the surrounding fluid and by promoting the pulsation of nearby blood vessels go.nature.com/3Td6Kwe
Thomas Pfeiffer retweeted
1/🧵 Lots of fuss and bother about the announcement from @neuralink today about having implanted their tech in a human brain for the first time. bbc.co.uk/news/technology-68…
Thomas Pfeiffer retweeted
Breaking down the risks and benefit for lecanemab, the amyloid beta-directed antibody vs Alzheimer's drug approved @US_FDA last year. It doesn't look good.
acpjournals.org/doi/10.7326/…
@AnnalsofIM




























